Statins for acute coronary syndrome
20 results
1 - 20
Statins for acute coronary syndrome 
Statins for acute coronary syndrome Stable (no update expected for reasons given in 'What's new')- Acute coronary syndrome and myocardial infarction
- Coronary heart disease
- Omega‐3 fatty acids for the primary and secondary prevention of cardiovascular disease New search for studies and content updated (conclusions changed)
PSK9 inhibitor alirocumab reduces nonfatal MI in patients after acute coronary syndrome, but at high cost (ODYSSEY OUTCOMES)- Intensive versus moderate statin therapy
- Better medication adherence with intervention; clinical outcomes unchanged
- Lipid lowering is beneficial for secondary prevention but not primary prevention in patients 75 years and older
- Routine or selective invasive strategy for acute coronary syndrome
- Ezetimibe for the prevention of cardiovascular disease and all-cause mortality events: Cochrane systematic review
- Risk of stroke after TIA is 2.8% at 1 month and 5.1% at 1 year
- Overview of new ACC/AHA lipid guidelines: here we go again